Michael J. Fisher, M.D.
Michael J. Fisher, M.D.
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 10th Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 10th Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: (215)590-2800
Email:
fisherm@email.chop.edu
fisherm@email.chop.edu
Education:
Eberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
M.D.
Harvard Medical School (cum Laude), 1994.
Permanent linkEberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
M.D.
Harvard Medical School (cum Laude), 1994.
Selected Publications
Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G, Rood BR, Packer RJ: Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatric Blood & Cancer September 2013.Avery RA, Ferner RE, Listernick R, Fisher MJ, Gutmann DH, Liu GT. : Visual Acuity in Children with Low Grade Gliomas of the Visual Pathway: Implications for Patient Care and Clinical Research. Journal Neurooncology 110(1-7), 2012.
Lang SS, Beslow LA, Gabel B, Judkins AR, Fisher MJ, Sutton LN, Storm PB, Heuer GG: Surgical Treatment of Brain Tumors in Infants Less than 6 months of Age and Literature Review World Neurosurgery 78(1-2): 137-44, 2012.
Campen CJ, Kranick SM, Kasner SE, Kessler SK, Zimmerman RA, Lustig L, Phillips PC, Storm PB, Smith SE, Ichord R, Fisher MJ: Cranial Irradiation Increases Risk of Stroke in Pediatric Brain Tumor Survivors. Stroke 43: 3035-3040, 2012.
Johnson KJ, Fisher MJ, Listernick RL, North KN, Schorry EK, Viskochil D, Weinstein M, Rubin JB, Gutmann DH: Parent of Origin and Sex Effects in Children with NF1 and Optic Gliomas. Familial Cancer 11(4): 653-6, 2012.
Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT.: Visual Outcomes in Children with Neurofibromatosis Type 1 Associated Optic Pathway Glioma Following Chemotherapy: A Multi-center Retrospective Analysis. Neuro-Oncology 14(6): 790-797, 2012.
Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ.: Retinal Nerve Fiber Layer Thickness in Children with Optic Pathway Gliomas. American Journal of Ophthalmology 151: 542-549, 2011.
Palmer Shawna L, Hassall Tim, Evankovich Karen, Mabbott Donald J, Bonner Melanie, Deluca Cinzia, Cohn Richard, Fisher Michael J, Morris E Brannon, Broniscer Alberto, Gajjar Amar: Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro-Oncology Aug 2010.
Packer Roger J, Jakacki Regina, Horn Marianna, Rood Brian, Vezina Gilbert, MacDonald Tobey, Fisher Michael J, Cohen Bruce: Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatric Blood & Cancer 52(7): 791-5, Jul 2009.
Chi Susan N, Zimmerman Mary Ann, Yao Xiaopan, Cohen Kenneth J, Burger Peter, Biegel Jaclyn A, Rorke-Adams Lucy B, Fisher Michael J, Janss Anna, Mazewski Claire, Goldman Stewart, Manley Peter E, Bowers Daniel C, Bendel Anne, Rubin Joshua, Turner Christopher D, Marcus Karen J, Goumnerova Liliana, Ullrich Nicole J, Kieran Mark W: Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. Journal of Clinical Oncology 27(3): 385-9, Jan 2009.